A carregar...
Somatostatin receptor radionuclide therapy in neuroendocrine tumors
Peptide receptor radionuclide therapy (PRRT) using (177)Lu-DOTATATE has been approved for the treatment of gastroenteropancreatic NETs. An understanding of benefits and risks is important for the appropriate implementation of this therapy. This review summarizes study data supporting the use of radi...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118168/ https://ncbi.nlm.nih.gov/pubmed/33608483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0360 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|